News
Issued by CareMed, not BioCryst Pharmaceuticals, Inc.
CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio
September 8, 2026 · Published on GlobeNewswire
It isn’t one of BioCryst Pharmaceuticals, Inc.’s news releases, so 6ix doesn’t show it on BioCryst Pharmaceuticals, Inc.’s page or send it as an alert.